AllianceBernstein Holding L.P. enters the back half of August with a striking split: the lending market has all but given up on the short thesis, yet options traders are quietly adding more downside protection than at almost any point in the past year.
The borrow story is the standout data point this week. Cost to borrow has collapsed — falling to just 0.10%, a drop of nearly 79% in a week and more than 92% over the past month. As recently as late July, CTB was running above 1.5%. That unwind reflects a lending market that has shifted from moderately tight to entirely relaxed. Availability confirms it: shares available to borrow now total nearly 2,000% of current short interest, up 35% on the week, meaning there is roughly 20 times more stock available to lend than is currently borrowed. Short interest itself is a non-issue at just 0.42% of free float, edging slightly lower on the week despite a 16% month-on-month rise in raw share terms — the absolute level remains too low to drive meaningful squeeze dynamics in either direction.
Options tell a more guarded story. The put/call ratio has climbed to 0.77, nearly 1.5 standard deviations above its 20-day average of 0.73, and is close to its 52-week high of 0.79. That is not extreme by market-wide standards, but for a stock that spent most of July trading well below a PCR of 0.72, the shift is notable. Downside protection demand has built steadily over the past two weeks — against a backdrop where the stock is down 2.3% on the week and 4.5% over the past month, now trading at $36.18.
The Street is modestly constructive but not excited. The mean analyst price target of roughly $39 implies about 8% upside from current levels, though the most recent moves — TD Cowen lifting its target to $38 while holding a Hold, Evercore ISI trimming to $39 while maintaining Outperform — suggest the consensus is marking time rather than making a directional call. The analyst data is around three weeks old at this point, which limits its freshness. On valuation, the stock trades at a PE of 9.8x, which has drifted down roughly 3% over the past month. The EV/EBITDA multiple at 2.7x is unusually low. The forward earnings trajectory looks more interesting: the 12-month forward EPS growth factor ranks in the 90th percentile of the universe, and the dividend score also sits at 90 — though the dividend history on file is stale and should not be used to frame a current yield thesis. The short score of 29.3 has edged lower all week, consistent with the borrow-cost collapse and flat positioning.
Among peers, SPGI and MCO each gained close to 2% on the week, while PFLT — which shares a near-identical weekly return profile with AB at -2.3% — suggests some of the week's weakness is sector-level rather than AB-specific. The next scheduled earnings event falls on October 28, giving the current setup several weeks to develop before a fundamental catalyst lands.
What to watch is whether the options bid for downside protection sustains or fades — if the put/call ratio normalises back toward its 20-day mean without the stock recovering, that would suggest the hedging pressure was tactical; if it holds near 52-week highs alongside continued price weakness, the divergence between a relaxed lending market and a cautious options market becomes the more durable story heading into Q3 results.
See the live data behind this article on ORTEX.
Open AB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
